Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A3284 Cathepsin S inhibitor1 CitationTarget: CathepsinsSummary: Blocks MHCII antigen presentation
-
A3655 NesbuvirTarget: Nonstructural protein 5B (NS5B)Summary: NS5B polymerase inhibitor
-
A3690 OtamixabanTarget: Factor XaSummary: Direct factor Xa inhibitors,potent and selective
-
A3791 Saquinavir mesylateSummary: HIV Protease Inhibitor
-
A3820 Simeprevir1 CitationTarget: HCV ProteasesSummary: Inhibitor of HCV NS3/4A protease
-
A4068 SNX-21121 CitationSummary: Hsp90 inhibitor,ATP-competitve,potent and selective
-
A4069 BMS-707035Target: HIV IntegrasesSummary: HIV-I integrase inhibitor,potent and specific
-
A4071 Fluorouracil (Adrucil)3 CitationTarget: Thymidylate SynthaseSummary: Antitumor agent;inhibitor of thymidylate synthase
-
A4077 BIBR 953 (Dabigatran, Pradaxa)Summary: Thrombin inhibitor,potent,reversible and direct
-
A4024 Danoprevir (RG7227)Target: HCV ProteasesSummary: HCV NS3/4A protease inhibitor